Viking Therapeutics appoints Dorothy Gemmell to board of directors

Reuters2026/07/23 11:12

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Viking Therapeutics appointed Dorothy Gemmell to its board, effective immediately.
Gemmell brings over 25 years in healthcare, digital health, commercialization; held president or chief commercial officer roles at GoodRx, Capsule, Havas Life.
Appointment comes as Viking advances next-generation metabolic programs, including preparations for a potential launch of obesity drug candidate VK2735.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viking Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA10817) on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viking Therapeutics appoints Dorothy Gemmell to board of directors

You may also like

Crypto prices